China National Medicines (SHSE:600511) Long-Term Capital Lease Obligation : ¥282 Mil (As of Mar. 2024)

View and export this data going back to 2002. Start your Free Trial

What is China National Medicines Long-Term Capital Lease Obligation?

China National Medicines's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥282 Mil.

China National Medicines's quarterly Long-Term Capital Lease Obligation increased from Sep. 2023 (¥132 Mil) to Dec. 2023 (¥205 Mil) and increased from Dec. 2023 (¥205 Mil) to Mar. 2024 (¥282 Mil).

China National Medicines's annual Long-Term Capital Lease Obligation declined from Dec. 2021 (¥197 Mil) to Dec. 2022 (¥183 Mil) but then increased from Dec. 2022 (¥183 Mil) to Dec. 2023 (¥205 Mil).

China National Medicines Long-Term Capital Lease Obligation Historical Data

The historical data trend for China National Medicines's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China National Medicines Long-Term Capital Lease Obligation Chart

China National Medicines Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

166.62

260.09

197.29

182.57

205.08

China National Medicines Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															157.52	151.60	132.46	205.08	282.17

China National Medicines (SHSE:600511) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

China National Medicines Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of China National Medicines's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

China National Medicines (SHSE:600511) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » China National Medicines Corp Ltd (SHSE:600511) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 12 A, Sanyuan West Lane, Yongwai, Chongwen District, Beijing, CHN, 100077

Website

http://www.cncm.com.cn

China National Medicines Corp Ltd focuses on producing special drugs and high-end prescription drugs. Its main goal is to provide customers with professional medical services. The company is also engaged in proprietary Chinese medicines, Chinese medicine decoction pieces, Chinese medicinal materials, chemical preparations, chemical raw materials, antibiotics, and biochemical drugs.

Executives

Chen Zhang Qing

Director

China National Medicines (SHSE:600511) Headlines

No Headlines